According to Altamira Therapeutics's latest financial reports the company's current earnings (TTM) are -$11.57 M. In 2017 the company made an earning of -$25 M an increase over its 2016 earnings that were of -$31.47 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2018 (TTM) | -$11.57 M | -53.74% |
2017 | -$25 M | -20.56% |
2016 | -$31.47 M | 1.27% |
2015 | -$31.08 M | 57.24% |
2014 | -$19.77 M | 23.77% |
2013 | -$15.97 M |